FDA Inspection 1252328 — AnazaoHealth Corporation

AnazaoHealth Corporation — FEI 3011152407

The FDA completed an inspection of AnazaoHealth Corporation on September 23, 2024 in Las Vegas, NV. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 23, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Las Vegas, NV (United States)